Chronic dyspepsia - persistent or recurrent upper abdominal pain, burning, or discomfort lasting weeks to months - is one of the most common gastrointestinal complaints worldwide. In India, where H. pylori infection rates reach 60-80% and self-medication with antacids is the norm, the condition is vastly under-investigated and under-treated. This page explains the Rome IV classification of functional dyspepsia, its two distinct subtypes, the role of H. pylori, when endoscopy is necessary, and how modern management differs from simply taking antacids every day.
✦ Quick Answers
What Is Chronic Dyspepsia?
Dyspepsia literally means "bad digestion." In clinical terms, it refers to a group of symptoms originating from the upper gastrointestinal tract - specifically the stomach and duodenum - that include upper abdominal pain, burning, postprandial fullness, early satiety, nausea, and belching. When these symptoms persist for three months or longer, the condition is termed chronic dyspepsia.
Chronic dyspepsia is not a single disease. It is a clinical syndrome - a pattern of symptoms that can arise from multiple causes. In roughly 70-80% of patients who undergo endoscopy for chronic dyspepsia, no structural abnormality (no ulcer, no tumour, no significant erosion) is found. These patients are classified as having functional dyspepsia - the stomach looks normal but does not function normally.
The remaining 20-30% have an identifiable structural cause: peptic ulcer disease, H. pylori gastritis with significant mucosal changes, NSAID-related gastropathy, or, less commonly, gastric malignancy. This distinction - functional versus structural - is the most important fork in the diagnostic road, and it determines the treatment path.
Rome IV Classification - EPS and PDS Subtypes
The Rome IV criteria are the current international standard for classifying functional gastrointestinal disorders. Under Rome IV, functional dyspepsia is divided into two subtypes based on the predominant symptom pattern. This classification is clinically useful because each subtype responds to different treatments.
Epigastric Pain Syndrome (EPS)
- Burning or pain in the upper abdomen (epigastrium)
- May occur on an empty stomach or between meals
- Not exclusively relieved by eating or passing stool
- Can mimic peptic ulcer pain
- Responds better to acid suppression (PPIs)
- Rome IV requires symptoms at least 1 day/week for 3 months
Postprandial Distress Syndrome (PDS)
- Bothersome fullness after a normal-sized meal
- Early satiety - unable to finish a normal meal
- Symptoms are meal-related and worsen after eating
- Often accompanied by nausea, bloating, belching
- Responds better to prokinetics (domperidone, itopride)
- Rome IV requires symptoms at least 3 days/week for 3 months
In clinical practice, approximately 30-40% of patients present with overlap - features of both EPS and PDS. These overlap patients tend to have more severe symptoms and may require combination therapy. Identifying the predominant pattern still helps prioritise the initial treatment approach.
| Feature | EPS (Epigastric Pain Syndrome) | PDS (Postprandial Distress Syndrome) |
|---|---|---|
| Core symptom | Burning or pain in the upper abdomen | Fullness after meals, early satiety |
| Timing | Fasting, between meals, or variable | During or shortly after meals |
| Meal relationship | May improve, worsen, or have no change with food | Consistently triggered or worsened by eating |
| Main mechanism | Visceral hypersensitivity, acid-related mucosal irritation | Impaired gastric accommodation, delayed emptying |
| First-line drug | Proton pump inhibitor (PPI) | Prokinetic (domperidone, itopride) |
| Overlap | 30-40% of patients have both patterns - combination therapy is often needed | |
What Causes Chronic Dyspepsia?
Helicobacter pylori infection
H. pylori is a bacterium that colonises the stomach lining, triggering chronic gastritis. This gastritis alters gastric acid secretion, impairs motility, and increases mucosal sensitivity - producing the full spectrum of dyspepsia symptoms. In India, H. pylori prevalence ranges from 60-80% depending on the region and socioeconomic group. It is transmitted through contaminated water and food, making reinfection a genuine concern in settings with poor sanitation.
International guidelines classify H. pylori-associated dyspepsia as a distinct entity - not functional dyspepsia. The practical implication is important: a patient with dyspepsia and positive H. pylori should be treated with eradication therapy first. Only if symptoms persist after successful eradication is the diagnosis revised to functional dyspepsia.
Functional dyspepsia - when the stomach looks normal but functions abnormally
In functional dyspepsia, the underlying problem is not a visible lesion but disordered gastric physiology. Three mechanisms are well established:
- Impaired gastric accommodation: The stomach normally relaxes as food enters, expanding to receive a meal. In functional dyspepsia, this relaxation is insufficient - the stomach remains tense, producing early satiety and postprandial fullness even from modest portions.
- Delayed gastric emptying: Present in approximately 25-35% of functional dyspepsia patients. Food remains in the stomach longer than normal, contributing to prolonged fullness, nausea, and bloating.
- Visceral hypersensitivity: The stomach's sensory nerves are abnormally sensitive. Normal gastric distension (a regular-sized meal) produces pain or discomfort that a healthy stomach would not register. This is the mechanism behind the burning and pain in EPS.
Other organic causes
- Peptic ulcer disease: Gastric or duodenal ulcers cause epigastric burning or pain. Duodenal ulcers classically produce hunger pain - relieved by food, returning 2-3 hours later. Gastric ulcers may worsen with eating. H. pylori and NSAID use are the two primary causes of peptic ulcers.
- NSAID-related gastropathy: Chronic use of painkillers - ibuprofen, diclofenac, aspirin, and similar drugs - damages the protective mucus layer of the stomach, causing erosions, ulcers, and chronic dyspepsia. This is an extremely common cause in India, where NSAIDs are available over the counter and used liberally for joint pain, headaches, and menstrual pain.
- Gallstone-related dyspepsia: Gallstones can produce upper abdominal discomfort, post-meal fullness, and bloating - particularly after fatty meals - even without classic biliary colic. This pattern is frequently confused with gastritis or acidity. An ultrasound identifies gallstones quickly.
- Gastro-oesophageal reflux disease (GERD): GERD and dyspepsia frequently coexist. The overlap can be confusing - heartburn suggests GERD, while upper abdominal pain and fullness suggest dyspepsia. Some patients have both, requiring treatment directed at each component.
- Gastric malignancy: Uncommon but critical to exclude. New-onset dyspepsia in patients above 55, with weight loss or any alarm feature, mandates endoscopy. Early detection transforms outcomes.
Alarm Features - When Endoscopy Is Mandatory
These features in a patient with chronic dyspepsia require prompt endoscopy:
- Unintended weight loss - even gradual loss of 3-5 kg over weeks
- Dysphagia - difficulty swallowing solids or liquids
- Persistent vomiting - especially vomiting of old food or large volumes
- GI bleeding - vomiting blood (haematemesis) or black, tarry stools (melaena)
- Iron-deficiency anaemia - unexplained drop in haemoglobin
- Palpable abdominal mass or lymphadenopathy
- Age above 55 with new-onset dyspepsia - the age threshold for mandatory endoscopy
- Family history of upper GI malignancy
- Progressive worsening over a short period (4-6 weeks)
- Symptoms unresponsive to 4-8 weeks of empirical therapy
When chronic dyspepsia is usually manageable without urgent endoscopy
- Age below 55, with no alarm features, and symptoms that respond to initial treatment
- Clear dietary triggers - oily food, spicy food, heavy meals - with improvement when triggers are avoided
- Known H. pylori-positive status responding to eradication therapy
- Symptoms stable for months without progression, weight loss, or bleeding
- Stress-related pattern - worsening during periods of pressure, improving during holidays or relaxed periods
- Mild intermittent symptoms that do not affect nutrition, weight, or daily activities
Test-and-Treat vs. Investigate-First - Which Strategy?
Two established strategies exist for managing chronic dyspepsia, and the choice between them depends on the patient's age, alarm features, and local H. pylori prevalence.
| Strategy | How It Works | Best For |
|---|---|---|
| Test-and-treat | Test for H. pylori first (breath test or stool antigen). If positive, prescribe eradication therapy. If negative or symptoms persist after eradication, start empirical PPI therapy for 4-8 weeks. Endoscopy only if still symptomatic. | Patients under 55 with no alarm features. Particularly effective in populations with high H. pylori prevalence (India: 60-80%). |
| Investigate-first | Proceed directly to upper GI endoscopy before starting treatment. Enables definitive diagnosis - ulcer, gastritis, GERD, malignancy, or normal (functional dyspepsia). | Patients above 55 with new-onset dyspepsia. Any patient with alarm features. Patients who have failed test-and-treat. Patients with significant anxiety about missed diagnosis. |
In the Indian context, where H. pylori prevalence is among the highest globally, the test-and-treat approach is cost-effective and appropriate for the majority of younger patients without alarm features. It avoids unnecessary endoscopy in many cases while identifying and treating the most common correctable cause. However, the threshold for proceeding to endoscopy should remain low - particularly when the initial strategy does not produce improvement within 8 weeks.
How Chronic Dyspepsia Is Treated
1. H. pylori eradication - the first and most important step when positive
A 14-day course of combination antibiotics with a proton pump inhibitor is the standard. In India, where antibiotic resistance is a growing concern, bismuth-based quadruple therapy or concomitant therapy regimens are increasingly recommended over traditional triple therapy. Confirmation of successful eradication by urea breath test or stool antigen - performed at least 4 weeks after completing therapy - is essential. Failed eradication requires a second-line regimen with different antibiotics guided by local resistance patterns.
2. Proton pump inhibitors (PPIs) - for EPS-predominant dyspepsia
PPIs (omeprazole, pantoprazole, rabeprazole) suppress gastric acid production and are the first-line pharmacological treatment for epigastric pain and burning. A standard-dose PPI for 4-8 weeks is the initial trial. Patients who respond are gradually stepped down. Those who do not respond should be re-evaluated - either with endoscopy or a change in treatment strategy. Long-term PPI use without a clear indication is not recommended.
3. Prokinetics - for PDS-predominant dyspepsia
Domperidone and itopride are the prokinetics most used in India. They accelerate gastric emptying and improve gastric accommodation, reducing postprandial fullness, early satiety, bloating, and nausea. Itopride has dual action - prokinetic and anti-emetic - and is well-tolerated for courses of 4-8 weeks. Long-term domperidone use requires cardiac monitoring (QT interval) and should be supervised.
4. Dietary and lifestyle modification
Practical Dietary Guidance for Chronic Dyspepsia
- Eat smaller, more frequent meals: Four to five moderate portions instead of two to three large ones. The traditional pattern of a heavy lunch and late, large dinner is one of the most consistent aggravating factors in Indian dyspepsia patients.
- Reduce fat and oil in daily cooking: Fat is the macronutrient that most slows gastric emptying. Cut down on deep-fried snacks (bhajia, samosa, pakora), reduce ghee in dal and sabzi, and favour steamed or lightly cooked preparations.
- Limit spice intensity: While moderate spice is generally tolerable, concentrated chilli - green chillies, red chilli powder in excess, raw garlic - can directly irritate an already sensitive gastric mucosa. Adjust gradually rather than eliminating all spice.
- Avoid known triggers: Tea and coffee on an empty stomach, carbonated drinks, alcohol, and smoking all worsen dyspepsia. Identify personal triggers through a simple 2-week food diary.
- Do not lie down immediately after eating: Wait at least 1.5-2 hours. A short walk after meals improves gastric motility.
- Stop unnecessary NSAIDs: If you are taking painkillers regularly for joint pain, headaches, or back pain, discuss alternatives with your doctor. NSAID gastropathy is one of the most preventable causes of chronic dyspepsia in India.
5. Neuromodulators - for refractory functional dyspepsia
When functional dyspepsia persists despite H. pylori eradication, PPI therapy, prokinetics, and dietary changes, the gut-brain axis is the next therapeutic target. Low-dose tricyclic antidepressants (amitriptyline 10-25 mg nightly) are the best-studied neuromodulators for functional dyspepsia. They are used not as antidepressants but to reduce visceral hypersensitivity - the stomach's abnormal sensitivity to normal distension. Mirtazapine and buspirone have also shown benefit in specific subtypes. These are specialist-prescribed and require monitoring.
6. Addressing structural causes
- Peptic ulcer disease: PPI therapy for 4-8 weeks heals most ulcers. H. pylori eradication prevents recurrence. NSAID cessation is mandatory if NSAIDs are the cause.
- Gallstone-related dyspepsia: Laparoscopic cholecystectomy resolves symptoms in the majority of patients. A daycare or one-night-stay procedure with rapid recovery.
- Gastric malignancy: Surgical resection with curative intent in operable disease. Early detection through timely endoscopy is the single most important factor in survival outcomes.
Antacids Are Not a Treatment Plan for Chronic Dyspepsia
If your indigestion has persisted for months - with antacids providing only temporary relief - a structured evaluation can identify the actual cause and the right treatment. H. pylori testing takes minutes. An endoscopy takes under ten.
Chronic Dyspepsia vs. GERD vs. Gallstone Dyspepsia - How to Tell Them Apart
| Feature | Chronic Dyspepsia | GERD | Gallstone Dyspepsia |
|---|---|---|---|
| Primary symptom | Upper abdominal pain, burning, fullness | Heartburn, acid taste, regurgitation | Post-meal fullness, right upper quadrant discomfort |
| Symptom location | Epigastrium (central upper abdomen) | Retrosternal (behind the breastbone), rising upward | Right upper abdomen, may radiate to right shoulder |
| Meal relationship | Variable - may worsen or have no clear meal link (EPS) or consistently meal-triggered (PDS) | Worsens after meals, especially with lying down | Triggered by fatty meals specifically |
| Key investigation | H. pylori test, endoscopy | Endoscopy, pH monitoring | Ultrasound abdomen |
| Definitive treatment | H. pylori eradication, PPI, prokinetics | PPI, lifestyle modification, fundoplication if refractory | Laparoscopic cholecystectomy |
The overlap between these three conditions is real and common. A patient may have functional dyspepsia and GERD, or gallstones and H. pylori. Careful history-taking, H. pylori testing, ultrasound, and endoscopy (when indicated) sort through the overlap and identify which conditions are contributing.
What Happens If Chronic Dyspepsia Is Left Untreated?
- Ongoing symptoms with declining quality of life: Persistent pain, fullness, and nausea lead to anxiety around eating, dietary restriction, social withdrawal from meals, and reduced work productivity. Functional dyspepsia, though not life-threatening, can be profoundly disabling.
- Untreated H. pylori: Left untreated, H. pylori gastritis persists for decades. It increases the risk of peptic ulcer disease, and over the very long term, raises the risk of gastric MALT lymphoma and gastric adenocarcinoma. Eradication eliminates this trajectory.
- Continued NSAID damage: Patients who self-medicate with painkillers while also taking antacids to manage the resulting dyspepsia are in a damaging cycle. NSAID gastropathy can progress to bleeding ulcers, perforation, and stricture formation.
- Missed structural pathology: Gallstones managed as "acidity" may progress to acute cholecystitis, CBD stones, or pancreatitis. Gastric malignancy attributed to routine indigestion may advance beyond curative treatment.
- Nutritional consequences: Chronic under-eating due to fear of symptoms leads to weight loss, iron and vitamin deficiencies, weakness, and poor wound healing - particularly concerning in elderly patients.
Recovery and Long-Term Outlook
| Intervention | Expected Improvement Timeline |
|---|---|
| H. pylori eradication | Symptom improvement within 2-4 weeks of completing treatment. Roughly 1 in 14 patients achieves complete lasting cure from eradication alone. Others improve partially and may need additional therapy. |
| PPI therapy (4-8 weeks) | Improvement in epigastric pain and burning within 1-2 weeks. Full benefit by 4-8 weeks. Response guides whether long-term maintenance is needed. |
| Prokinetics | Improvement in fullness, early satiety, and nausea within 2-4 weeks. Best results in PDS-predominant patients. |
| Dietary modification | Noticeable improvement within 1-2 weeks of switching to smaller, lower-fat meals. The single most durable intervention for long-term symptom control. |
| Neuromodulators | Gradual improvement over 4-8 weeks. Used for refractory functional dyspepsia under specialist supervision. Full benefit may take 8-12 weeks. |
| Cholecystectomy (for gallstone dyspepsia) | Improvement in post-meal symptoms within 2-4 weeks of surgery. Full dietary normalisation by 6-8 weeks. |
Functional dyspepsia is a chronic, relapsing condition. Most patients achieve good symptom control with the right combination of dietary discipline, targeted medication, and stress management - but flares during periods of dietary excess, work pressure, or life stress are expected and manageable. The goal is long-term control, not necessarily permanent cure.
Chronic Dyspepsia in India - What Makes It Different Here
- H. pylori prevalence of 60-80%: India has one of the highest H. pylori infection rates in the world, driven by contaminated water sources and crowded living conditions. This means that in the Indian population, H. pylori-associated dyspepsia is far more common than in Western countries - and the test-and-treat strategy has an even higher yield here. Yet the majority of patients with chronic indigestion in India have never been tested for H. pylori.
- Over-the-counter NSAID culture: Ibuprofen, diclofenac, and combination painkillers are purchased freely from pharmacies without prescription for headaches, joint pain, backache, and menstrual cramps. Chronic NSAID use is one of the most common preventable causes of dyspepsia and peptic ulcer disease in India. Patients often take antacids to counteract the stomach pain caused by the very painkillers they are using - a cycle that delays proper diagnosis.
- Spicy food as a cultural factor: Concentrated chilli, raw garlic, vinegar-based pickles, and heavily spiced gravies can directly irritate the gastric mucosa in patients with underlying gastritis or functional dyspepsia. The issue is not spice itself but the intensity and frequency - daily exposure to high-capsaicin preparations on an already sensitised stomach amplifies symptoms.
- Self-medication with antacids and churan: Digestive churan, hing-based tonics, ajmo water, and OTC antacids are the first (and often only) response to dyspepsia for millions of Indians. These provide temporary symptom relief but do not address the underlying cause - whether that is H. pylori, NSAID gastropathy, or functional dyspepsia requiring specific treatment.
- Late-night heavy meals: The Indian dinner pattern - eating the largest or second-largest meal of the day at 9-10 PM and lying down within an hour - maximises postprandial symptoms. This cultural eating pattern is a consistent aggravating factor in chronic dyspepsia.
- Stigma around mental health: The gut-brain axis is a genuine therapeutic target in functional dyspepsia. When doctors recommend stress management or low-dose neuromodulators, patients sometimes resist, interpreting it as "the doctor thinks my problem is in my head." In reality, visceral hypersensitivity is a well-documented physiological abnormality - not a psychological weakness.
- Antibiotic resistance concerns: India faces rising rates of clarithromycin and metronidazole resistance in H. pylori strains. This means that traditional triple therapy (which relies on these antibiotics) may fail in 20-30% of cases. Newer regimens - bismuth quadruple therapy, concomitant therapy - are increasingly necessary but under-prescribed in primary care settings.
Common Questions in Gujarati & Hinglish
Meaning: "It's been a month of stomach trouble - I'm managing with acidity tablets - how long can this go on?" - Acidity ni tablet symptom dabave chhe, cause treat nathi karti. Pahelu kaam H. pylori test karavvo - India ma 60-80% loko ne aa infection hoy chhe. Positive hoy to 14-day treatment thi lasting relief male chhe. Negative hoy to doctor cause shodhse - tablet chalava rehvu long-term solution nathi.
Meaning: "What is H. pylori? Can I get it? How is the test done?" - H. pylori ek bacteria chhe je pet ni andar ni layer ma rahe chhe ane chronic gastritis kare chhe. India ma bahuj common chhe - dushit paani ane khana thi faile chhe. Test simple chhe - breath test ya stool test - 15-20 minute ma result aave chhe. PPI dawai 2 athvadiya pahela bandh karvi pade chhe accurate result maate.
Meaning: "My stomach trouble is getting worse daily and I'm losing weight - what should I do?" - Weight loss sathe worsening dyspepsia ek alarm feature chhe - tarataj doctor ne batavo. Endoscopy karavi padse ulcer, gastritis, ya koi serious problem check karva maate. Delay na karo - jaldi investigation thi serious conditions vahelij pakdaay chhe ane treatment saaru thay chhe.
Meaning: "My stomach is terrible after oily food - but home cooking always has oil - what can I do?" - Fat gastric emptying slow kare chhe - aa physiology chhe. Ghar na cooking ma changes karo: tel ni quantity halving karo, deep-fry ni jagya air-fry ya bake karo, ghee measure karine vaapro. Gallstones pan check karavo - fatty food pachhi specifically kharab thatu hoy to ultrasound karavo.
Meaning: "When I stopped painkillers my stomach improved - but what about my knee pain?" - Aa bahuj common problem chhe India ma. NSAID (ibuprofen, diclofenac) pet ne damage kare chhe. Doctor ne batavo - paracetamol safe alternative chhe, ane jyaare NSAID zaruri hoy to sathe PPI cover aapi shake chhe. Knee pain maate physiotherapy ane proper ortho evaluation karao - pet ne damage karata painkillers koi solution nathi.
Meaning: "My endoscopy is normal - then why does my stomach still hurt?" - Aa functional dyspepsia chhe - pet normal dikhay chhe pan normally kaam nathi kartu. Stomach ni nerves vadhu sensitive hoy chhe (visceral hypersensitivity) ane emptying slow hoy chhe. Aa real medical problem chhe - "man ma chhe" nathi. Treatment available chhe - prokinetics, low-dose neuromodulators, ane dietary changes thi improvement thay chhe.
Frequently Asked Questions
Related Pages
Stop Managing Symptoms - Start Treating the Cause
Chronic dyspepsia has identifiable causes and targeted treatments.
An H. pylori test takes minutes. An
endoscopy takes under ten.
Book a consultation with Dr Samir Contractor at Sterling
Hospital, Vadodara.
Medical Disclaimer: The information on this page is intended for patient education only and does not constitute medical advice, diagnosis, or treatment. Every patient's condition is unique. Do not self-diagnose or self-treat based on online content. Always consult a qualified medical professional for personalised evaluation and management. If you are experiencing severe symptoms - persistent vomiting, blood in vomit or stool, rapid weight loss, or inability to eat - visit the nearest emergency department immediately.
